The Prognostic Value of Circulatory Cancer Cells after Debulking of Advanced Ovarian Tumor
Mohamed, A. (2020). The Prognostic Value of Circulatory Cancer Cells after Debulking of Advanced Ovarian Tumor. EKB Journal Management System, 80(3), 1103-1109. doi: 10.21608/ejhm.2020.108888
Attia Mohamed. "The Prognostic Value of Circulatory Cancer Cells after Debulking of Advanced Ovarian Tumor". EKB Journal Management System, 80, 3, 2020, 1103-1109. doi: 10.21608/ejhm.2020.108888
Mohamed, A. (2020). 'The Prognostic Value of Circulatory Cancer Cells after Debulking of Advanced Ovarian Tumor', EKB Journal Management System, 80(3), pp. 1103-1109. doi: 10.21608/ejhm.2020.108888
Mohamed, A. The Prognostic Value of Circulatory Cancer Cells after Debulking of Advanced Ovarian Tumor. EKB Journal Management System, 2020; 80(3): 1103-1109. doi: 10.21608/ejhm.2020.108888

The Prognostic Value of Circulatory Cancer Cells after Debulking of Advanced Ovarian Tumor

The Egyptian Journal of Hospital Medicine
Article 25, Volume 80, Issue 3, July 2020, Page 1103-1109  XML PDF (759.79 K)
Document Type: Original Article
DOI: 10.21608/ejhm.2020.108888
View on SCiNiTO View on SCiNiTO
Author
Attia Mohamed email
Department of Obstetrics and Gynecology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt
Abstract
Background: There is a recent focus on circulatory cancer cells (CCCs) as a prognostic biomarker for many malignant cancers. We aimed to investigate the association between the presence of CCCs before the surgery in patients with advanced ovarian cancer (AOC) and the survival of these patients. Methods: We included in this study 30 women with AOC and eligible for debulking. Blood samples were obtained before and after the surgery and the CCCs were counted using the optimized tapered-slit filter technique. The association between these cells and the survival of these patient was analyzed. Results: The median age of the included women was 57 years, while the median follow-up period was 29.3 months. There was no difference between the counts of CCCs before and after the debulking (P>0.05). There was no association between the post-debulking CCCs and the 3-year progression-free survival (PFS) (P>0.05) or the overall survival (OS) (P>0.05). There was an association between frequent presence of lymph node involvement and the presence of post-debulking CCCs (P<0.01). However not significant, there was an association between the post-debulking CCCs and the PFS in women with very advanced cancers (P>0.05). Conclusion: The presence of post-debulking CCCs was proven to be associated with bad prognosis as it showed to be associated with poor PFS. Further studies are required to enforce these findings. 
Keywords
Ovarian cancer; Circulatory cancer cells; Prognosis
Statistics
Article View: 145
PDF Download: 300